27 completed, 8 unknown, 4 enrolling by invitation, 4 terminated. 26 Not applicable, 7 Phase 1, 5 Phase 2, 1 Early Phase 1, 1 Phase 3.
Follow Safety: new trials by email Literature Review of Safety trials Research Report on Safety
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reducing Firearm Suicide Among Veterans: Evaluating the Effectiveness of Peer-Delivered Lethal Means Counseling Peer Engagement and Exploration of Responsibility and Safety, Active Control - Suicide, Secure Firearm Storage | Phase 1 / Phase 2 | Not yet recruiting | VA Office of Research and Development | 100 | 2026-07-01 | 2026-03-12 |
| Safety and Efficacy of Romiplostim in Treatment of Chronic ITP in Children Safety and efficacy of Romiplostim in Treatment of chronic ITP in children - Romiplostim N01, ITP | Not yet recruiting | Assiut University | 100 | 2025-11-01 | 2025-10-09 | |
| Incorporation of Safe Sleep Education Into m-Health Technology Safety in Seconds mobile app: Safe Sleep Education, Safety in Seconds mobile app: Car Seat Safety Education - Sudden Infant Death | Not applicable | Completed | Johns Hopkins University | 130 | 2025-07-01 | 2026-09-17 |
| Suicide Preventive Psychosocial Treatment for Youths Safe Alternatives for Teens and Youth (SAFETY), Enhanced Treatment As Usual - Suicide Attempt, Suicidal and Self-injurious Behavior | Not applicable | Recruiting | Karolinska Institutet | 282 | 2025-05-28 | 2026-10-23 |
| A Long-term Follow-up Study in Participants Who Received CS-101 Safety and efficacy assessments - Beta-Thalassemia | Enrolling by invitation | CorrectSequence Therapeutics Co., Ltd | 5 | 2025-01-18 | 2026-02-10 | |
| Centering Gender Affirming Resources in Higher Education Giving Information for Trauma Support and Safety (GIFTSS) Training, Centering gender Affirming Resources in higher Education (CARE) Learning Modules - Sexual Violence, Drinking Heavy | Not applicable | Recruiting | University of Pittsburgh | 100 | 2024-12-11 | 2026-10-16 |
| Evaluating Safety and Efficacy of Autologous Gene-edited Muscle Stem Cells (GenPHSats-bASKet) GenPHSat injection (Safety), GenPHSat injection (Efficacy), Muscle Biopsy (Safety) - LGMD | Phase 1 / Phase 2 | Unknown | Simone Spuler, MD | 6 | 2024-07-01 | 2023-08-03 |
| A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301 Safety and efficacy assessments - Sickle Cell Disease, Transfusion-dependent Beta-Thalassemia | Enrolling by invitation | Editas Medicine, Inc. | 54 | 2024-06-17 | 2025-04-02 | |
| PLANTS Pilot Trial PLANTS, EMAILS - Alcohol Drinking, Social Acceptance | Not applicable | Completed | University of Pittsburgh | 99 | 2023-06-28 | 2025-04-04 |
| Preventing Suicide With Safe Alternatives for Teens and Youths (SAFETY) Safe Alternatives for Teens and Youths (SAFETY), Supportive Therapy - Suicide and Self-harm | Not applicable | Completed | Region Stockholm | 30 | 2022-12-02 | 2025-04-11 |
| A Long-Term Follow-Up Study of Participants With Cystinosis Who Previously Received CTNS-RD-04 Safety and Efficacy Assessments - Cystinosis | Enrolling by invitation | Stephanie Cherqui | 50 | 2022-11-14 | 2024-07-03 | |
| Women and Child, Safety, Health, and Empowerment Women and Child, Safety, Health and Empowerment (WC-SHE) - Gender-based Violence | Not applicable | Completed | Johns Hopkins University | 150 | 2022-10-21 | 2023-12-14 |
| The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006), Cellular Immunity, Humoral Immunity - SARS-CoV-2, Safety | Not applicable | Unknown | Zhongnan Hospital | 1000 | 2022-08-13 | 2022-10-12 |
| Pharmacists Interventions on Patients Diabetic, and Obese Patients in the UAE: Randomized Controlled Trials. Pharmaceutical intervention - Hypertension, Diabete Type 2 | Not applicable | Unknown | University of Sharjah | 720 | 2022-08-01 | 2022-08-04 |
| Using the Multiphase Optimization Strategy to Adapt Cognitive Processing Therapy Modified A-B-C: Working with Events, Thoughts, and Feelings, Challenging Questions, Patterns of Problematic Thinking - Stress Disorders, Post-Traumatic | Not applicable | Completed | VA Office of Research and Development | 271 | 2022-08-01 | 2026-06-10 |
| "Safety in Dementia": An Online Caregiver Intervention Safety in Dementia - Caregivers, Decision Making | Not applicable | Completed | University of Colorado, Denver | 500 | 2022-05-22 | 2026-05-14 |
| Laparoscopic-guided TAP Block vs Epidural Analgesia Safety and efficiency of post operative analgesia between laparoscopic-assisted TAP block and epidural analgesia - Post Operative Pain | Not applicable | Unknown | Oulu University Hospital | 210 | 2022-02-01 | 2022-01-28 |
| Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults Poly-ICLC (Hiltonol®) or Placebo - COVID - 19 | Phase 1 | Completed | Oncovir, Inc. | 43 | 2021-07-21 | 2023-05-18 |
| A Long-Term Follow-up Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02 Safety and efficacy assessments - Type 1 Gaucher Disease | Terminated | AVROBIO | 4 | 2021-07-06 | 2023-08-29 | |
| Impact of Cuddle and Calm Booklets on Parent-Child Emotional Connection a Nurture-based Children's Book Poem book about relational health, Poem book about physical health and safety - Emotional Problem | Not applicable | Withdrawn | Columbia University | 2021-05-01 | 2023-02-22 |
Showing 20 of 52. Sign in to see all of them.
Obesity (6) · Suicide (5) · Depression (3) · Self-Injurious Behavior (3) · beta-Thalassemia (3) · Alcohol Drinking (2) · Anemia (2) · Anemia, Sickle Cell (2) · Genetic Diseases, Inborn (2) · Psychological Well-Being (2) · Stress Disorders, Post-Traumatic (2) · Suicide, Attempted (2) · Agnosia (1) · Alcohol-Related Disorders (1) · Alcoholism (1)
University of Pittsburgh (3) · AVROBIO (2) · Genetix Biotherapeutics Inc. (2) · Johns Hopkins University (2) · Oncovir, Inc. (2) · University of Colorado, Denver (2) · University of Washington (2) · VA Office of Research and Development (2) · Assiut University (1) · Baxalta now part of Shire (1) · Boston Medical Center (1) · Celgene (1) · Columbia University (1) · CorrectSequence Therapeutics Co., Ltd (1) · Duke University (1)
United States (28) · Canada (5) · China (3) · France (3) · Italy (3) · Australia (2) · Spain (2) · Sweden (2) · Brazil (1) · Finland (1) · Germany (1) · Greece (1) · Norway (1) · South Korea (1) · Thailand (1)
Andres M Salazar, MD (1) · Anjulika Chawla, MD (1) · Annsofie Adolfsson, Med Dr (1) · Bushra Sabri, PhD (1) · Caron Zlotnick, PhD (1) · Christine Gulla, MD (1) · Claire Houtsma, PhD (1) · Dong-Ik Kim, Professor (1) · Elisabeth Flo, PysD, PhD (1) · Elisha Wachman, MD (1) · Elizabeth Miller, PhD (1) · Farrokh Dehdashti, MD (1) · Frederick J Zimmerman, Ph.D. (1) · Heikki Huhta, PhD (1)
PMID 19564349, PMID 20549206, PMID 20615924, PMID 21467219, PMID 22065672, PMID 23032745, PMID 35075288, PMID 8727138, PMID 11020022, PMID 110688, PMID 11099992, PMID 11440640, PMID 11487589, PMID 12627513, PMID 12846756, PMID 16011702, PMID 16051812, PMID 16197446, PMID 16554548, PMID 16625202, PMID 17295916, PMID 17395581, PMID 17720522, PMID 18003768, PMID 18073382, PMID 18398750, PMID 18778201, PMID 18797818, PMID 19005182, PMID 19355966, PMID 19360120, PMID 19420084, PMID 19713308, PMID 20038196, PMID 20054291, PMID 20389020, PMID 21135147, PMID 21149657, PMID 21233416, PMID 21632857, PMID 21694919, PMID 22086194, PMID 22318524, PMID 22349644, PMID 22379685, PMID 22512017, PMID 22894575, PMID 23089735, PMID 23114898, PMID 23114904
1IK2CX002877-01A1 (1), 2017 (1), 2019 (1), K01AA027564 (1), R01AA023260 (1), R01DK084475 (1), R01DK115434 (1), R01HD096798 (1), R21CA182945 (1), R34MH078082 (1), U54HD047905 (1)